Biotech · Private company
Finch Research and Development LLC.
Track this companyFree. Adds Finch Research and Development LLC. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- CP101Phase 3 · Recurrent C. Difficile InfectionClinicalTrials.gov · fetched Nov 12, 2026
- CP101Phase 2 · Clostridium Difficile InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Full Spectrum MicrobiotaPhase 2 · Clostridium Difficile Infection RecurrenceClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)PHASE3 · TERMINATED · started Nov 15, 2021ClinicalTrials.gov NCT05153499 · fetched Nov 12, 2026
- Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile InfectionPHASE2 · COMPLETED · started May 1, 2018ClinicalTrials.gov NCT03497806 · fetched Nov 12, 2026
- Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. DiffPHASE2 · COMPLETED · started May 8, 2017ClinicalTrials.gov NCT03110133 · fetched Nov 12, 2026